"Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the Surveillance)"

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions
Heart Valve Disease
Interventions
OTHER

Decellularized human heart valves

Decellularized human aortic heart valves

Trial Locations (8)

2333

Leids Universitair Medisch Centrum, LUMC, Leiden

3000

Universitair Ziekenhuis Leuven, UZL, Leuven

8032

Kinderspital Zürich, Zurich

30625

Hannover Medical School, Hanover

35128

Azienda Ospedaliera di Padova, U.O.C. di Cardiochirurgia Pediatrica e Cardiopatie Congenite, Padua

40225

University of Düsseldorf, Department of Cardiovascular Surgery, Düsseldorf

08036

University Hospital Clinic de Barcelona, Cardiovascular Surgery administrative area, Barcelona

SW3 6NP

Royal Brompton and Harefield National Health Service Trust, London

All Listed Sponsors
collaborator

Hannover Medical School

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Azienda Ospedaliera di Padova

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Vienna General Hospital

OTHER

lead

corlife

INDUSTRY

NCT02527629 - "Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the Surveillance)" | Biotech Hunter | Biotech Hunter